[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-335164-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-335164-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","targeting-cleavage-of-c-terminal-fragment-of-cytoskeletal-filamin-a-in-cancers-article-overview","Targeting Cleavage of C-Terminal Fragment of Cytoskeletal Filamin A in Cancers - Article Overview","","Human cancers show altered levels of the actin-binding cytoskeletal protein filamin A (FLNA). In mammals, FLNA contains an N-terminal actin-binding domain followed by 24 immunoglobulin-like repeats separated by two hinge regions; cleavage generates the C-terminal 90 kDa fragment (FLNACT). FLNACT regulates actin cytoskeleton remodeling and supports signaling and nuclear transport, influencing transcriptional programs by interacting with multiple partners. Because FLNA cleavage may drive cancer initiation and progression, recent work explores blocking this cleavage as a therapeutic strategy; this review updates targeting approaches and their implications for future treatment.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/targeting-cleavage-of-c-terminal-fragment-of-cytoskeletal-filamin-a-in-cancers-article-overview/335164/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/targeting-cleavage-of-c-terminal-fragment-of-cytoskeletal-filamin-a-in-cancers-article-overview/335164.png","ImageObject",300,407,{"name":42,"@type":43},"Asher","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-30","2026-09-21",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",6,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What is FLNA and what changes in cancers are described?","Question",{"text":63,"@type":64},"FLNA is an actin-binding cytoskeletal protein whose levels are altered in human cancers. This altered expression and cleavage are linked to processes important for tumor initiation and progression.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How does cleavage of FLNA relate to the C-terminal fragment FLNACT?",{"text":68,"@type":64},"FLNA contains two hinge regions between specific immunoglobulin-like repeats. Cleavage at these hinges produces a naturally occurring C-terminal 90 kDa fragment called FLNACT.",{"name":70,"@type":61,"acceptedAnswer":71},"Why is blocking FLNA cleavage considered a potential cancer therapy?",{"text":72,"@type":64},"The article explains that FLNA cleavage contributes to actin remodeling, signaling, and nuclear activities that regulate transcriptional programs relevant to cancer. Recent studies therefore propose inhibiting FLNA cleavage to interfere with these cancer-associated functions.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},335164,1790898096,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,105,110,114,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":102,"show_sort_weight":103,"slug":104},"Technology",50,"technology",{"id":106,"doc_module":4,"doc_module_name":25,"category_name":107,"show_sort_weight":108,"slug":109},7,"Healthcare",40,"healthcare",{"id":111,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":112,"slug":113},8,30,"research-report",{"id":115,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},9,"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":111,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":123,"language":139,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":140,"faqs":141,"seo_title":142,"seo_description":12,"update_tm":143,"read_time":144,"preview_page_count":4},687197207639,"https://ap-avatar.wpscdn.com/davatar_a8503ba1806abce46bf441b54a3ca4cd","cells  \nPerspective  \nTargeting Cleavage of C-Terminal Fragment of Cytoskeletal Filamin A in Cancers  \nOzgur Cakici 1, Sashidar Bandaru 2, Grace Yankun Lee 1, Dyar Mustafa 3 and Levent M. Akyürek 1,2,3, *  \nCitation: Cakici, O.; Bandaru, S.; Lee, G.Y.; Mustafa, D.; Akyürek, L.M. Targeting Cleavage of C-Terminal Fragment of Cytoskeletal Filamin A in Cancers. Cells 2024, 13, 1394. [https://](https://)[ ](https://)[doi.org/10.3390/cells13161394](doi.org/10.3390/cells13161394)  \nAcademic Editors: Francisco Rivero and Annette Müller-Taubenberger  \nReceived: 19 July 2024  \nRevised: 15 August 2024  \nAccepted: 19 August 2024  \nPublished: 21 August 2024  \nCopyright: © 2024 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license ([https://](https://)[ ](https://)[creativecommons.org/licenses/by/](creativecommons.org/licenses/by/)[ ](creativecommons.org/licenses/by/)[4.0/](4.0/)) .  \n1 Sabri Ülker Center for Metabolic Research, Department of Molecular Metabolism, Harvard T.H. Chan School of Public Health, Boston, MA 02115, USA; [ocakici@hsph.harvard.edu](ocakici@hsph.harvard.edu) (O.C.); [gylee@hsph.harvard.edu](gylee@hsph.harvard.edu) (G.Y.L.)  \n2 Department of Clinical Pathology, Sahlgrenska University Hospital, Västra Götalandsregionen,  \n413 45 Gothenburg, Sweden; [sashidar.bandaru@medkem.gu.se](sashidar.bandaru@medkem.gu.se)  \n3 Department of Laboratory Medicine, Institute of Biomedicine, University of Gothenburg, Sahlgrenska Academy, 405 30 Gothenburg, Sweden; [dyar.mustafa@gu.se](dyar.mustafa@gu.se)  \n* Correspondence: [levent.akyurek@gu.se](levent.akyurek@gu.se); Tel.: +46-7-2200-9830  \nAbstract: Human cancers express altered levels of actin-binding cytoskeletal filamin A (FLNA) protein. FLNA in mammals consists of an actin-binding domain at its N-terminus that is followed by 24 immunoglobulin-like repeat modules interrupted by two hinge regions between repeats 15–16 and 23–24. Cleavage of these hinge regions produces a naturally occurring C-terminal 90 kDa fragment of FLNA (FLNACT ) that physically interacts with multiple proteins with diverse functions. This cleavage leads to actin cytoskeleton remodeling, which in turn contributes to cellular signaling, nucleocytoplasmic shuttling of transcriptional factors and nuclear receptors, and regulation of their transcriptional activities that are important for initiation and progression of cancers. Therefore, recent studies have proposed blocking FLNA cleavage as a means of cancer therapy. Here, we update how FLNA cleavage has been targeted by different approaches and their potential implications for future treatment of human cancers.  \nKeywords: cytoskeleton; filamin; cleavage; cancer; inhibition  \n1. Structure and Function of Filamin A  \nThe family of actin-binding cytoskeletal filamins consists of three members, filamin A (FLNA), FLNB, and FLNC [1] . Filamins exist in both homo-and heterodimeric structures. Both FLNA and FLNB are structurally similar to each other and abundantly expressed throughout the body, whereas expression of FLNC is limited to cardiac and skeletal muscles. Structurally, filamins have an actin-binding domain (ABD) at their N-terminus, followed by a rod-domain and a dimerization domain at the carboxy-terminus [2] . The ABD has two CH domains for actin-binding. FLNA exists as V-shaped dimers that can link F-actin into parallel bundles or orthogonal networks (Figure 1) . The flexibility of FLNA and the actin– FLNA ratio determines the type of actin structure that forms. Additionally, transmembrane receptors can be linked to the actin cytoskeleton by FLNA.  \nIn addition to its widely known cytoskeletal function, FLNA has surprisingly been shown to interact with a functionally diverse group of molecules involved in the regulation of cellular signaling as a scaffold and transcriptional activity [3,4] . The number of known interacting partn","cbCaiiXd8wtDmj6N","https://ap.wps.com/l/cbCaiiXd8wtDmj6N","pdf",1717926,"English","# Abstract\n# Keywords\n# Structure and Function of Filamin A\n## Filamin family members and domains\n## Actin-binding and cytoskeletal organization\n## FLNA interactions and nuclear functions\n# FLNACT generation and cancer relevance\n# Figures and model descriptions","[{\"question\":\"What is FLNA and what changes in cancers are described?\",\"answer\":\"FLNA is an actin-binding cytoskeletal protein whose levels are altered in human cancers. This altered expression and cleavage are linked to processes important for tumor initiation and progression.\"},{\"question\":\"How does cleavage of FLNA relate to the C-terminal fragment FLNACT?\",\"answer\":\"FLNA contains two hinge regions between specific immunoglobulin-like repeats. Cleavage at these hinges produces a naturally occurring C-terminal 90 kDa fragment called FLNACT.\"},{\"question\":\"Why is blocking FLNA cleavage considered a potential cancer therapy?\",\"answer\":\"The article explains that FLNA cleavage contributes to actin remodeling, signaling, and nuclear activities that regulate transcriptional programs relevant to cancer. Recent studies therefore propose inhibiting FLNA cleavage to interfere with these cancer-associated functions.\"}]","Targeting Cleavage of C-Terminal Fragment of Cytoskeletal Filamin A in Cancers - Article Overview | PDF",1790009858,25]